(NASDAQ. GRAL) lost approximately 50% of its market value after disclosing that the NHS Galleri randomized trial failed to meet its primary endpoint. Shareholders who lost money on GRAL are encouraged to submit their information now ... Levi, Esq ... 21% ... .
Investigation examines whether Grail's forward guidance omitted material headwinds known to management at the time. Investigation examines whether Grail's forward guidance omitted material headwinds known to management at the time ... .
GRAL) investors lost approximately half the value of their holdings when the stock plunged roughly 50% following disclosure that the NHS Galleri trial missed its primary endpoint.
SAN DIEGO, Feb. 24, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S ... (NASDAQ. GRAL) ... https.//www.rgrdlaw.com/cases-grail-inc-investigation-gral.html. You can also contact attorney J.C.